RxDoctor Payments Data

Jared Brock, PA

Physician Assistant · Franklin, INNPI 1073551248

Payments from drug & device makers

$2,917in general payments, 2019–2025

Across 180 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$539
  • GSK$370
  • Novo Nordisk$294
  • Lilly USA, LLC$123
  • Takeda Pharmaceuticals U.S.A., Inc.$115
  • Otsuka America Pharmaceutical, Inc.$105
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$2,917100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,917 in reported general payments places this provider in the 85th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$87,019
Medicare patients
264
Services billed
2,891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate83$108,395
EliquisApixaban109$101,265
OzempicSemaglutide75$88,637
JardianceEmpagliflozin64$66,050
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$55,262
XareltoRivaroxaban24$32,950
MounjaroTirzepatide17$23,842
Breo ElliptaFluticasone/Vilanterol42$20,214
FarxigaDapagliflozin Propanediol12$17,189
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$16,580
MyrbetriqMirabegron15$12,225
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$7,859
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$5,271
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$4,688
Albuterol Sulfate HfaAlbuterol Sulfate100$3,557

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$27$108,39583 claims
PfizerEliquis$66$101,265109 claims
Novo NordiskOzempic$294$88,63775 claims
GSKTrelegy Ellipta, Breo Ellipta$370$75,47683 claims
Boehringer IngelheimJardiance$85$66,05064 claims
AstraZenecaFarxiga, Breztri Aerosphere$26$33,77024 claims
Johnson & JohnsonXarelto$72$32,95024 claims
Lilly USA, LLCMounjaro$123$23,84217 claims
Astellas Pharma US IncMyrbetriq$17$12,22515 claims
AbbVieSynthroid$539$2,59248 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$1,916224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Franklin

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →